Publisher
Springer Berlin Heidelberg
Reference22 articles.
1. Herzig RH, Lazarus HM, Wolff SN et al. (1985) High-dose cytosine arabinoside therapy with and without anthracycline antibiotics for remission induction of acute nonlymphoblastic leukemia. J Clin Oncol 3: 992–997
2. Kantarjian H, Estey E, Plunkett W et al. (1986) Phase I-II clinical and pharmacologic studies of high-dose cytosine arabinoside in refractory leukemia. Am J Med 81: 387–394
3. Decker RW, Ho WG, Champlin RE (1987) Phase II study of amsacrine and high-dose cytarabine for resistant acute myelogenous leukemia. Cancer Treat Rep 71: 881–882
4. Willemze R, Zwaan FE, Colpin G, Keuning JJ (1982) High-dose cytosine arabinoside in the management of acute leukemia. Scand J Haematol 29: 141–146
5. Heinemann V, Jehn U (1990) Rationales for a pharmacologically optimized treatment of acute non-lymphocytic leukemia with cytosine arabinoside. Leukemia 4: 790–796